quinazolines has been researched along with pravastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, LX; He, LP; Liang, ZS; Mo, CG; Qin, YQ; Wang, XD; Xie, J; Yang, F; Zhou, SX | 1 |
Kanamitsu, K; Kusuhara, H; Schuetz, JD; Sugiyama, Y; Takeuchi, K | 1 |
2 other study(ies) available for quinazolines and pravastatin
Article | Year |
---|---|
Pravastatin and C reactive protein modulate protease- activated receptor-1 expression in vitro blood platelets.
Topics: Adenosine Diphosphate; Blood Platelets; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Humans; Immunoblotting; P-Selectin; Platelet Aggregation; Pravastatin; Pyrroles; Quinazolines; Receptor, PAR-1; Receptors, Thromboxane A2, Prostaglandin H2; Scavenger Receptors, Class E; Thrombin | 2016 |
Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.
Topics: 2,4-Dichlorophenoxyacetic Acid; Acridines; Adenosine Triphosphate; Animals; Biological Transport; Blood-Brain Barrier; Brain; Central Nervous System; Cyclic GMP; Humans; Kinetics; Male; Methotrexate; Mice, Inbred C57BL; Multidrug Resistance-Associated Proteins; Ochratoxins; Pravastatin; Quinazolines; Quinolines; Tetrahydroisoquinolines; Thiophenes; Uric Acid | 2017 |